Maharashtra Woman Dies Of Rabies 3 Days After Completing Vaccine Course

Kolhapur: A 21-year-old woman from Maharashtra’s Kolhapur died of rabies three days after she completed the anti-rabies vaccination course.

The woman, Srishti Shinde, was bitten by a stray dog on February 3 on Bhausingji Road. She was on her way to Shaniwar Peth and had stopped on the road to answer a phone call when a stray dog bit her on her leg.

However, days later, she developed a fever and lost strength in both her legs.

Srishti Shinde was admitted to a private hospital where several tests were conducted and was put on a ventilator after her condition worsened. The test reports revealed that she was infected with rabies.

Shinde was later taken to a government hospital for further treatment, but she died the next day.

Srishti Shinde’s death has raised questions about how she contracted rabies despite completing the vaccine course. Her family is asking whether the vaccine was not kept at the required temperature.

Related Posts

Odisha Receives Investment Commitments Worth ₹7,043 Cr in Pharma & Medtech

Odisha has received investment commitments worth ₹7,043 crore across the pharmaceutical and medical technology sectors, marking a major step in strengthening the state’s position as an emerging healthcare manufacturing hub.…

Cough Syrup Racket Busted: Kingpin Shubham Jaiswal skips ED summons; Here’s what happens next

Mastermind of India’s massive codeine cough syrup racket skips ED summons- what’s next for Shubham Jaiswal? With arrest warrants, Red Corner Notices, and cross-border drug links, the investigation could expose…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Odisha Receives Investment Commitments Worth ₹7,043 Cr in Pharma & Medtech

Odisha Receives Investment Commitments Worth ₹7,043 Cr in Pharma & Medtech

Cough Syrup Racket Busted: Kingpin Shubham Jaiswal skips ED summons; Here’s what happens next

Cough Syrup Racket Busted: Kingpin Shubham Jaiswal skips ED summons; Here’s what happens next

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

Aytu BioPharma launches depression drug EXXUA in U.S. market

Aytu BioPharma launches depression drug EXXUA in U.S. market

Delhi govt carries out 27 raids against fake medicine

Delhi govt carries out 27 raids against fake medicine

Odisha Pharma Summit 2025 to Explore Opportunities in Pharmaceutical Sector on December 16

Odisha Pharma Summit 2025 to Explore Opportunities in Pharmaceutical Sector on December 16